Results 171 to 180 of about 364,037 (241)

A diffusion model analysis of task set inertia and task set reconfiguration in ADHD. [PDF]

open access: yesJ Int Neuropsychol Soc
Hlutkowsky CO   +4 more
europepmc   +1 more source

Residual permutation tests for feature importance in machine learning

open access: yesBritish Journal of Mathematical and Statistical Psychology, EarlyView.
Abstract Psychological research has traditionally relied on linear models to test scientific hypotheses. However, the emergence of machine learning (ML) algorithms has opened new opportunities for exploring variable relationships beyond linear constraints.
Po‐Hsien Huang
wiley   +1 more source

Tubular MAG3 Extraction Rate is a Predictor of Short-Term and Long-Term Outcome After Kidney Transplantation: A Prospective Observational Study. [PDF]

open access: yesClin Nucl Med
Buckenmayer A   +7 more
europepmc   +1 more source

Effects of Common Food Additives Kappa‐, Iota‐ and Lambda‐Carrageenans on Intestinal Epithelial Cell Activation and Barrier Disruption

open access: yesClinical &Experimental Allergy, EarlyView.
Carrageenans, widely used food additives, disrupted intestinal epithelial integrity in a gut‐on‐a‐chip model. All types (κ‐, ɩ‐, λ‐) induced cytotoxicity, inflammation and tight junction (TJ) disruption, triggering TNF‐mediated immune responses. λ‐Carrageenan had the most severe effects, supporting the Epithelial Barrier Theory linking food additives ...
Na Sun   +13 more
wiley   +1 more source

Trust and fairness in platform–supplier contracts: Navigating supplier concerns in the sharing economy

open access: yesDecision Sciences, EarlyView.
Abstract Trust and fairness are critical to the sustainable development of the sharing economy, particularly in platform–supplier relationships, where numerous individual suppliers offer access to their durable assets without transferring ownership. Motivated by the real‐world phenomenon of personalized wages and informed through direct interactions ...
Ying Yin, Xishu Li
wiley   +1 more source

Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study.

open access: yesJAMA Neurol
Cree BAC   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy